JP2008530106A5 - - Google Patents

Download PDF

Info

Publication number
JP2008530106A5
JP2008530106A5 JP2007555215A JP2007555215A JP2008530106A5 JP 2008530106 A5 JP2008530106 A5 JP 2008530106A5 JP 2007555215 A JP2007555215 A JP 2007555215A JP 2007555215 A JP2007555215 A JP 2007555215A JP 2008530106 A5 JP2008530106 A5 JP 2008530106A5
Authority
JP
Japan
Prior art keywords
carbon atoms
optionally substituted
alkyl
substituted
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007555215A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008530106A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/004562 external-priority patent/WO2006088720A2/en
Publication of JP2008530106A publication Critical patent/JP2008530106A/ja
Publication of JP2008530106A5 publication Critical patent/JP2008530106A5/ja
Pending legal-status Critical Current

Links

JP2007555215A 2005-02-15 2006-02-09 9−置換テトラサイクリン Pending JP2008530106A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65326905P 2005-02-15 2005-02-15
PCT/US2006/004562 WO2006088720A2 (en) 2005-02-15 2006-02-09 9-substituted tetracyclines

Publications (2)

Publication Number Publication Date
JP2008530106A JP2008530106A (ja) 2008-08-07
JP2008530106A5 true JP2008530106A5 (cg-RX-API-DMAC7.html) 2009-02-05

Family

ID=36676182

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007555215A Pending JP2008530106A (ja) 2005-02-15 2006-02-09 9−置換テトラサイクリン

Country Status (12)

Country Link
US (1) US7812008B2 (cg-RX-API-DMAC7.html)
EP (1) EP1848686A2 (cg-RX-API-DMAC7.html)
JP (1) JP2008530106A (cg-RX-API-DMAC7.html)
CN (1) CN101119964A (cg-RX-API-DMAC7.html)
AR (1) AR053131A1 (cg-RX-API-DMAC7.html)
AU (1) AU2006214543A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0607353A2 (cg-RX-API-DMAC7.html)
CA (1) CA2597870A1 (cg-RX-API-DMAC7.html)
GT (1) GT200600063A (cg-RX-API-DMAC7.html)
MX (1) MX2007009863A (cg-RX-API-DMAC7.html)
TW (1) TW200640469A (cg-RX-API-DMAC7.html)
WO (1) WO2006088720A2 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101489987A (zh) * 2006-04-17 2009-07-22 特瓦制药工业有限公司 四环素衍生物的分离
US8198470B2 (en) * 2006-04-24 2012-06-12 Teva Pharmaceutical Industries Ltd. Crystalline form II of tigecycline and processes for preparation thereof
DE202007019460U1 (de) * 2006-04-24 2012-10-24 Teva Pharmaceutical Industries Ltd. Kristalline Tigecyclin-Formen
EP2086926A2 (en) * 2006-11-29 2009-08-12 Teva Pharmaceutical Industries Ltd. Crystalline forms of tigecycline and processes for preparation thereof
MX2008009727A (es) * 2006-11-30 2009-01-09 Teva Pharma Procesos para la preparacion de 9-haloacetamidominociclinas.
US20080214869A1 (en) * 2007-03-01 2008-09-04 Sergei Fine Processes for purification of tigecycline
US7939513B2 (en) 2007-09-07 2011-05-10 Dr. Reddy's Laboratories Limited Tetracycline derivatives as antibacterial agents
CN105367440A (zh) * 2008-08-08 2016-03-02 四相制药公司 C7-氟取代的四环素化合物
CA2761241C (en) 2009-05-08 2018-02-27 Tetraphase Pharmaceuticals, Inc. Tetracycline compounds
WO2011025982A2 (en) * 2009-08-28 2011-03-03 Tetraphase Pharmaceuticals, Inc. Tetracycline compounds
CN101955443B (zh) * 2010-09-30 2012-05-23 浙江大学 一种替加环素中间体及其盐的制备方法
WO2013013504A1 (zh) * 2011-07-26 2013-01-31 山东亨利医药科技有限责任公司 替加环素衍生物
DK2890673T3 (en) 2012-08-31 2019-03-18 Tetraphase Pharmaceuticals Inc tetracycline
CN107759503A (zh) * 2016-08-16 2018-03-06 四川科伦博泰生物医药股份有限公司 一种四环素衍生物及其用途
DK3529236T3 (da) 2016-10-19 2024-05-13 Tetraphase Pharmaceuticals Inc Krystalformer af eravacyclin

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2482055A (en) 1948-02-11 1949-09-13 American Cyanamid Co Aureomycin and preparation of same
US3007965A (en) 1959-02-13 1961-11-07 American Cyanamid Co New tetracyclines produced by streptomyces aureofaciens
US3043875A (en) 1959-10-22 1962-07-10 Pfizer & Co C Halogenated tetracycline derivatives and processes for their preparation
FR1430859A (cg-RX-API-DMAC7.html) 1960-05-23 1966-05-25
US3338963A (en) 1960-10-28 1967-08-29 American Cyanamid Co Tetracycline compounds
US3148212A (en) 1961-12-22 1964-09-08 American Cyanamid Co Reductive alkylation process
US3360557A (en) 1963-05-10 1967-12-26 American Cyanamid Co 9-hydroxytetracyclines and a process of preparing same
USRE26253E (en) 1963-05-17 1967-08-15 And z-alkylamino-g-deoxytetracycline
US3341585A (en) 1966-05-06 1967-09-12 American Cyanamid Co Substituted 7-and/or 9-amino-6-deoxytetracyclines
US3360561A (en) 1967-06-19 1967-12-26 American Cyanamid Co Nitration of tetracyclines
US3518306A (en) 1968-02-19 1970-06-30 American Cyanamid Co 7- and/or 9-(n-nitrosoalkylamino)-6-demethyl-6-deoxytetracyclines
US4806529A (en) 1982-11-18 1989-02-21 Trustees Of Tufts College, Tufts University Tetracycline activity enhancement
US5494903A (en) 1991-10-04 1996-02-27 American Cyanamid Company 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
US5420272A (en) * 1992-08-13 1995-05-30 American Cyanamid Company 7-(substituted)-8-(substituted)-9-](substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
US5442059A (en) * 1992-08-13 1995-08-15 American Cyanamid Company 9-[(substituted glycyl)amido)]-6-demethyl-6-deoxytetracyclines
US5328902A (en) * 1992-08-13 1994-07-12 American Cyanamid Co. 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
AU1279095A (en) * 1994-02-17 1995-09-04 Pfizer Inc. 9-(substituted amino)-alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibiotics
JP4963771B2 (ja) * 2000-07-07 2012-06-27 トラスティーズ・オブ・タフツ・カレッジ 7、8および9−置換テトラサイクリン化合物
EA201000388A1 (ru) * 2001-03-13 2010-10-29 Пэрэтек Фамэсьютикэлс, Инк. Замещенные соединения тетрациклина (варианты), фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния субъекта
WO2004064728A2 (en) * 2003-01-16 2004-08-05 Paratek Pharmaceuticals, Inc. Use of specific tetracycline compounds in therapy

Similar Documents

Publication Publication Date Title
JP2008530106A5 (cg-RX-API-DMAC7.html)
JP2008500391A5 (cg-RX-API-DMAC7.html)
JP2007513170A5 (cg-RX-API-DMAC7.html)
JP2007511527A5 (cg-RX-API-DMAC7.html)
JP2006514626A5 (cg-RX-API-DMAC7.html)
JP2013508373A5 (cg-RX-API-DMAC7.html)
JP2017523169A5 (cg-RX-API-DMAC7.html)
JP2014500870A5 (cg-RX-API-DMAC7.html)
JP2014509322A5 (cg-RX-API-DMAC7.html)
JP2006509842A5 (cg-RX-API-DMAC7.html)
JP2005533040A5 (cg-RX-API-DMAC7.html)
JP2005514373A5 (cg-RX-API-DMAC7.html)
JP2007511535A5 (cg-RX-API-DMAC7.html)
JP2012515142A5 (cg-RX-API-DMAC7.html)
JP2006509749A5 (cg-RX-API-DMAC7.html)
JP2011523952A5 (cg-RX-API-DMAC7.html)
KR102776189B1 (ko) 발베나진의 고상 형태
JP2012513416A5 (cg-RX-API-DMAC7.html)
JP2012505872A5 (cg-RX-API-DMAC7.html)
JP2010540477A5 (cg-RX-API-DMAC7.html)
JP2008518900A5 (cg-RX-API-DMAC7.html)
JP2007515411A5 (cg-RX-API-DMAC7.html)
JP2009511511A5 (cg-RX-API-DMAC7.html)
JP2007506792A5 (cg-RX-API-DMAC7.html)
JPWO2020006432A5 (cg-RX-API-DMAC7.html)